Skip to main content

Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy

  • Armen Kocharian (a1), Reza Shabanian (a1), Mohammad Rafiei-Khorgami (a1), Abdolrazagh Kiani (a1) and Giv Heidari-Bateni (a1)...

We aimed to determine the effect of supplementation with coenzyme Q10 on conventional therapy of children with cardiac failure due to idiopathic dilated cardiomyopathy. In a prospective, randomized, double-blinded, placebo-controlled trial, we randomized 38 patients younger than 18 years with idiopathic dilated cardiomyopathy to receive either coenzyme Q10, chosen for 17 patients, or placebo, administered in the remaining 21. Echocardiographic systolic and diastolic function parameters were determined for every patient at baseline, and after 6 months of supplementation. The index score for cardiac failure in children as established in New York was used for assessing the functional class of the patients. After 6 months supplementation, 10 patients randomized to receive coenzyme Q10 showed improvements in the grading of diastolic function, this being significantly more than that achieved by those randomized to the placebo group (p value = 0.011). The mean score for the index of cardiac failure index for those receiving coenzyme Q10 was also lower than the control group (p value = 0.024).

Our results, therefore, indicate that administration of coenzyme Q10 is useful in ameliorating cardiac failure in patients with idiopathic dilated cardiomyopathy through its significant effect on improving diastolic function.

Corresponding author
Correspondence to: Giv Heidari-Bateni, MD/MPH, General Practitioner, Children’s Medical Center, 62 Gharib Street, 14194, Tehran, Iran. Tel: +98 2166507851; Fax: +98 21 66930024; E-mail:
Hide All
1. Hadj A, Pepe S, Rosenfeldt F. The clinical application of metabolic therapy for cardiovascular disease. Heart Lung Circ 2007; 16 (Suppl): S56S64.
2. Singh U, Devaraj S, Jialal I. Coenzyme Q10 supplementation and heart failure. Nutr Rev 2007; 65: 286293.
3. Bhagavan HN, Chopra RK. Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy. Clin Nutr 2005; 24: 331338.
4. Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme 10. Proc Natl Acad Sci 1985; 82: 42404244.
5. Poggesi L, Galanti G, Comeglio M, Toncelli L, Vinci M. Effect of coenzyme Q10 on left ventricular function in patients with dilative cardiomyopathy. Current Therapeutic Research 1991; 49: 878886.
6. Permanetter B, Rossy W, Klein G, Weingartner F, Seidl KF, Blomer H. Ubiquinone (coenzyme q10) in the long-term treatment of idiopathic dilated cardiomyopathy. Eur Heart J 1992; 13: 15281533.
7. Munkholm H, Hansen HHT, Rasmussen K. Coenzyme Q10 treatment in serious heart failure. BioFactors 1999; 9: 285289.
8. Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, Aroney CN. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Card 1999; 33: 15491552.
9. Keogh A, Fenton S, Leslie C, et al. Randomized double-blind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure. Heart Lung Circ 2003; 12: 135141.
10. Elshershari H, Ozer S, Ozkutlu S, Ozme S. Potential usefulness of coenzyme Q10 in the treatment of idiopathic dilated cardomyopathy in children. Int J Cardiol 2003; 88: 101102.
11. Soongswang J, Sangtawesin C, Durongpisitkul K, et al. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children. Pediatr Cardiol 2005; 26: 361366.
12. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841842.
13. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: A new method of quantifying chronic heart failure severity in children. J Pediatr 2001; 138: 644648.
14. O’Leary PW. Pediatric diastology: use and limitations of Doppler echocardiography in the evaluation of ventricular diastolic function in children. Prog Pediatr Cardiol 1999; 10: 8393.
15. O’Leary PW, Durongpisitkul K, Cordes TM, et al. Diastolic ventricular function in children: a Doppler echocardiographic study establishing normal values and predictors of increased ventricular end-diastolic pressure. Mayo Clin Proc 1998; 73: 616628.
16. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function – a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357366.
17. Colan SD, Parness IA, Spevak PJ, Sanders SP. Developmental modulation of myocardial mechanics: age and growth-related alterations in afterload and contractility. J Am Coll Cardiol 1992; 19: 619629.
18. Tissières P, Aggoun Y, Da Cruz E, et al. Comparison of classifications for heart failure in children undergoing valvular surgery. J Pediatr 2006; 149: 210215.
19. Little WC, Cheng C-P. Diastolic dysfunction. Cardiol Rev 1998; 6: 231239.
20. Vivekananthan K, Kalapura T, Mehra M, et al. Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Am J Cardiol 2002; 90: 517520.
21. Peltier M, Slama M, Garbi S, Enriquez-Sarano ML, Goissen T, Tribouilloy CM. Prognostic value of Doppler-derived myocardial performance index in patients with left ventricular systolic dysfunction. Am J Cardiol 2002; 90: 12611263.
22. Redfield MM, Jacobsen SJ, JrBurnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194202.
23. Fischer M, Baessler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24: 320328.
24. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002; 105: 15031508.
25. Auslender M. Pathophysiology of pediatric heart failure. Prog Pediatr Cardiol 2002; 11: 175184.
26. Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006; 40: 445453.
27. Silver MA, Langsjoen PH, Szabo S, Patil H, Zelinger A. Effect of Atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. Am J Cardiol 2004; 94: 13061310.
28. Langsjoen PH, Langsjoen PH, Folkers K. Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment. Clin Invest 1993; 71 (Suppl): S140S144.
29. Oda T. Recovery of load-induced left ventricular diastolic dysfunction by coenzyme Q10: echocardiographic study. Mol Aspects Med 1994; 15 (Suppl): S149S154.
30. Lönnrot K, Pörsti I, Alho H, Wu X, Hervonen A, Tolvanen JP. Control of arterial tone after long-term coenzyme Q10 supplementation in senescent rats. Br J Pharmacol 1998; 124: 15001506.
31. Belardinelli R, Tiano L, Littarru GP. Oxidative stress, endothelial function and coenzyme Q10. Biofactors 2008; 32: 129133.
32. Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 2007; 28: 22492255.
33. Grodecki PV, Klein AL. Pitfalls in the echo-Doppler assessment of diastolic dysfunction. Echocardiography 1993; 10: 213234.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Cardiology in the Young
  • ISSN: 1047-9511
  • EISSN: 1467-1107
  • URL: /core/journals/cardiology-in-the-young
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 4
Total number of PDF views: 32 *
Loading metrics...

Abstract views

Total abstract views: 388 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st February 2018. This data will be updated every 24 hours.